Foundation Fighting Blindness Retinal Degeneration Fund

Track

Insider profile

Performance

Overall performance
Performance over holding periods
30 days 90 days 120 days
Average return 7% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Foundation Fighting Blindness Retinal Degeneration Fund's trades of Opus Genetics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
411.41
Quantity 12,192 -38.3%
Value US$1,479,216
Transaction date
Sale
Price
480.81
Quantity 72,883 -8.8%
Value US$2,467,738
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-20 2026-05-18
S Sale
12,192 -38.3%
411.41
US$1,479,216 		12,192 -38.3% 411.41 US$1,479,216
2025-12-11 2025-12-09
S Sale
72,883 -8.8%
480.81
US$2,467,738 		72,883 -8.8% 480.81 US$2,467,738